Skip to content

Feasibility of allocating the freshest available red blood cells to critically ill patients: a pilot study

Critically ill patients receiving freshest available red blood cells compared to standard care feasibility study

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12610000736044
Enrollment
72
Registered
2010-09-03
Start date
2010-09-06
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The purpose of this study is to know if it is feasible to do a randomized controlled trial by allocating the freshest available red blood cells in critically patients, versus standard care.

Interventions

Transfusion of freshest available red blood cells. The freshest red blood cell is defined by the shortest number of days between the collection of the blood and its delivery. The freshest available red blood cells will be take in the back of the fridge of the blood bank The patients receiving the freshest red blood cells will be allocated in this group after randomisation This allocation remains throughout the stay in intensive care or for the study period (6weeks) The methods used in transfus

Transfusion of freshest available red blood cells. The freshest red blood cell is defined by the shortest number of days between the collection of the blood and its delivery. The freshest available red blood cells will be take in the back of the fridge of the blood bank The patients receiving the freshest red blood cells will be allocated in this group after randomisation This allocation remains throughout the stay in intensive care or for the study period (6weeks) The methods used in transfusion, the amoount of blood transfused depend on the needs of the patients and on the doctor's prescription. These characteristics are not defined by the protocole.

Sponsors

Monash University
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Primary purpose
Prevention
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients hospitalised in the intensive care unit Age equal or higher than 18 years Require administration of at least one red blood cells unit

Exclusion criteria

Palliative care Transplant Oncology and Haematology patients Patients with known red blood cells antibodies requiring antigen negative units (Patients will be withdrawn from the study if the requirement for antigen-specific red cells is identified after randomisation)

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026